42 results
Summary of the therapeutic uses of adrenergic agonists
Table of Catecholamine Pressors, Non-Catecholamines, Alpha and Beta Receptor
therapeutic uses of adrenergic ... Non-Catecholamines, Alpha and ... Receptor Targets and ... Therapeutic Uses #Pharmacology ... #Beta #Table #Comparison
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
formulations, comparison ... and considerations ... #pharmacology ... #medications #comparison ... #drugs #treatment
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
DOACs) for VTE treatment ... and prevention ... - Comparison Table ... VTE #Management #Pharmacology ... #Comparison #Table
Pharmacological Treatment of Hepatorenal Syndrome (HRS)

Midodrine - Alpha agonist incr blood pressure incr renal perfusion pressure
Pharmacological Treatment ... Vasoconstriction of systemic and ... Norepinephrine Alpha, beta-adrenergic ... Nephrology #Management #Pharmacology ... #Medications #Treatment
Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism.
Initial treatment ... renal bone disease and ... hypocalcaemia and ... the first-line treatments ... #Pharmacology #Pathophysiology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... risks, and therapy ... #pharmacology #pharmacotherapy ... #table #comparison ... endocrinology #treatment
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
action, side effect and ... diagrams, tables and ... NSAIDS #management #pharmacology ... #table #comparison ... #medications #treatment
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
the long-term treatment ... Contraindications and ... Cautions, Monitoring and ... WeightLoss #AACE #2016 #Pharmacology ... #Table #Comparison
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
decrease rate and ... • MOA: Inhibit B.adrenergic ... block alpha & beta adrenergic ... Vaughan #Williams #Pharmacology ... Classification #Classes #pathophysiology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... • MOA: Inhibit B.adrenergic ... block alpha & beta adrenergic ... Antiarrhythmics #Pharmacology ... Classification #Classes #pathophysiology